Three women entrepreneurs to compete in eosera® Foundation Pitch Competition
FORT WORTH, Texas, Oct. 21, 2025 /PRNewswire/ -- eosera® Foundation Staff -- Three women entrepreneurs are practicing their presentations and...
Clinical Trial
DEA Marijuana Tribunal System Collapses: Terry Cole’s First 100 Days Will Decide Whether the Corruption Ends or Continues
"The Supreme Court gave us the roadmap, and DOJ confirmed it," Duane Boise said. "Now it's up to the Trump...
ANSN Symposium Redefines Astaxanthin Science and Innovation
BURLINGTON, N.J., Oct. 21, 2025 /PRNewswire/ -- AstaReal Inc. announces the first virtual symposium hosted by the AstaReal Network for...
Knowtex Selected by U.S. Department of Veterans Affairs to Deploy Ambient Clinical AI
Women-founded, YC-backed company, Knowtex brings ambient AI to the nation's largest integrated healthcare system SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/...
Alethios Launches to Lower the Barriers to Human Health Research
Alethios debuts with proven customers, strong study metrics, and the Alethios Study Planner — a $100/month tool making health evidence generation...
Pain Consultants of East Tennessee Selected as the Initial “Flagship Office” to Demonstrate the Power of the Adhere+ Remote Therapeutic Monitoring Platform
Flagship initiative aims to tackle Tennessee's chronic pain and opioid epidemic while generating real-world evidence to guide national adoption of...
Improving Translational Research and Clinical Trials with Digital Pathology, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how expert-led pathology supports translational research and clinical trials at every stage. Attendees will gain...
Beyond the bench: The advantages of GMP over USP compounding in early phase development, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insights about the differences between GMP and USP compounding in research. Attendees will learn that...
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting
Company to Spotlight Comprehensive Hip & Knee Portfolios and Latest Advancements in Robotics, Including the mBôs™ System Following Recent Acquisition...
Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med’s Specialized Treatment Revolution
Winter Park, Florida--(Newsfile Corp. - October 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment...
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
Three Independent Studies Published in “Alzheimer’s Research & Therapy,” “Journal of Alzheimer’s Disease,” and “Radiology” Validate Nexalin’s Non-Invasive Approach with...
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO)...
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
- Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT®, the innovative alpha-radiation cancer therapy...
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to...
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Upon Approval of NDA Quoin Will Receive Seven Years Marketing Exclusivity for QRX003 in the US Orphan Drug Designation previously...
Avalyn Announces Multiple Presentations at the Pulmonary Fibrosis Foundation (PFF) Summit 2025
Presentations to Highlight Patient Experience Research, AURA-IPF Phase 2 Trial Design for AP02, and Long-Term Safety Data for AP01BOSTON, Oct....
Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology’s Kidney Week
WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of...
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak®...
Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025
~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension...